MCDA EVIDEM REFERENCE VALUE FRAMEWORK FOR DRUG EVALUATION AND DECISION MAKING IN SPAIN

被引：7
|
作者：
Badia, X. [1 ]
Gil, A. [1 ]
Shepherd, J. [1 ]
机构：
[1] Omakase Consulting, Barcelona, Spain
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.1063
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP169
引用
收藏
页码：S179 / S179
页数：1
相关论文
共 50 条
  • [1] RELATIVE VALUE OF EVIDEM MCDA FRAMEWORK FOR REFLECTIVE DRUG EVALUATION AMONG HOSPITAL PHARMACISTS IN PORTUGAL
    Mirco, A.
    Paulino, E.
    Farinha, M. H.
    Gil, A.
    Shepherd, J.
    Badia, X.
    VALUE IN HEALTH, 2018, 21 : S184 - S184
  • [2] DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN
    Poveda, J. L.
    Badia, F. J.
    Chugani Mahtani, D.
    Abad, M. R.
    Arias, P.
    Guillen-Navarro, E.
    Jarque, I
    Posada-De-La-Paz, M.
    Vitoria, I
    VALUE IN HEALTH, 2019, 22 : S862 - S862
  • [3] Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain
    Badia, Xavier
    Chugani, Divya
    Reyes Abad, Maria
    Arias, Patricia
    Guillen-Navarro, Encarnacion
    Jarque, Isidro
    Posada, Manuel
    Vitoria, Isidro
    Luis Poved, Jose
    EXPERT OPINION ON ORPHAN DRUGS, 2019, 7 (7-8): : 363 - 372
  • [4] Evidence and value: Impact on decision making - The EVIDEM framework and potential applications
    Goetghebeur, M. M.
    Wagner, M.
    Khoury, H.
    Levitt, R.
    Erickson, L. J.
    Rindress, D.
    VALUE IN HEALTH, 2008, 11 (03) : A183 - A184
  • [5] RELATIVE VALUE OF EVIDEM MCDA FRAMEWORK FOR REFLECTIVE DRUG EVALUATION AMONG THERAPEUTIC POSITIONING REPORT EVALUATORS FROM THE SPANISH AGENCY OF MEDICINES
    Hernandez, C.
    Blazquez, A.
    Gil, A.
    Badia, X.
    VALUE IN HEALTH, 2017, 20 (09) : A699 - A699
  • [6] Bridging Health Technology Assessment (HTA) and Efficient Health Care Decision Making with Multicriteria Decision Analysis (MCDA): Applying the EVIDEM Framework to Medicines Appraisal
    Goetghebeur, Mireille M.
    Wagner, Monika
    Khoury, Hanane
    Levitt, Randy J.
    Erickson, Lonny J.
    Rindress, Donna
    MEDICAL DECISION MAKING, 2012, 32 (02) : 376 - 388
  • [7] CAN THE ETHICAL DILEMMAS FOR HEALTH CARE DECISION MAKING ON DRUG REIMBURSMENT BE TACKLED THROUGH HOLISTIC MCDA: AN ADAPTATION OF THE EVIDEM FRAMEWORK IN REAL-WORLD SETTING - THE CATALAN
    Badia, X.
    Khoury, H.
    Merino-Montero, S.
    Fontanet, M.
    Torrent-Farnell, J.
    Catalan, A.
    Prat, A.
    Gilabert, Perramon A.
    Goetghebeur, M. M.
    VALUE IN HEALTH, 2016, 19 (03) : A264 - A264
  • [8] DRUG EVALUATION AND DECISION MAKING IN CATALONIA: DEVELOPMENT AND VALIDATION OF A METHODOLOGICAL FRAMEWORK BASED ON MULTI-CRITERIA DECISION ANALYSIS (MCDA) FOR ORPHAN DRUGS
    Gilabert-Perramon, Antoni
    Torrent-Farnell, Josep
    Catalan, Arancha
    Prat, Alba
    Fontanet, Manel
    Puig-Peiro, Ruth
    Merino-Montero, Sandra
    Khoury, Hanane
    Goetghebeur, Mireille M.
    Badia, Xavier
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2017, 33 (01) : 111 - 120
  • [9] VALIDATING A MULTI-CRITERIA DECISION ANALYSIS (MCDA) FRAMEWORK FOR HEALTH CARE DECISION MAKING
    Lieferink, M. A.
    Til, J. A., V
    Groothuis-Oudshoorn, K.
    Goetghebeur, M. M.
    Dolan, J. G.
    VALUE IN HEALTH, 2011, 14 (07) : A424 - A424
  • [10] Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada
    Tony, Michele
    Wagner, Monika
    Khoury, Hanane
    Rindress, Donna
    Papastavros, Tina
    Oh, Paul
    Goetghebeur, Mireille M.
    BMC HEALTH SERVICES RESEARCH, 2011, 11
12345